Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis.

IL-4 is a cytokine with important antiapoptotic activity. We have analyzed the role that tyrosine-containing domains within the cytoplasmic tail of IL-4R alpha play in IL-4-mediated protection from apoptosis. 32D cells expressing a wt huIL-4R alpha or one truncated at aa 557 were protected by huIL-4 from apoptosis while cells expressing a receptor truncated at aa 657 were not, suggesting that the carboxyl-terminal domain signals protection from apoptosis. However, changing Y713 within this region to phenylalanine had no effect. To analyze the contribution of tyrosine-containing domains independently, we transplanted regions of the huIL-4R alpha to a truncated form of the huIL-2R beta that could not signal protection from apoptosis. Transplantation of the huIL-4R alpha domains containing Y497 or Y713 partially prevented cell death and together signaled protection from apoptosis in response to IL-2 as well as the wt IL-2R beta. Mutation of Y497 and Y713 to phenylalanine inhibited protection. In contrast, transplantation of the domain containing the potential STAT6-docking tyrosines alone had no effect, yet it inhibited the protection mediated by the other domains. Although IL-4R alpha signals Shc and SH2-containing inositol phosphatase (SHIP) phosphorylation, we could not establish an association between their activation and protection from apoptosis. Taken together, this study suggests that the domains of the huIL-4R alpha containing Y497 and Y713 positively regulate protection from apoptosis while the domain containing the STAT6 docking sites suppresses this protection, and that additional signaling molecules other than insulin receptor substrate-1 (IRS1), Shc, or SHIP may be involved in antiapoptotic signaling.

[1]  G. Longmore,et al.  Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. , 1998, Journal of immunology.

[2]  J. O’Shea.  Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.

[3]  P. Ferrara,et al.  Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complex , 1997 .

[4]  J. Kinet,et al.  The Emerging Field of Receptor-Mediated Inhibitory Signaling: SHP or SHIP? , 1996, Cell.

[5]  Ling-mei Wang,et al.  IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. , 1996, Journal of immunology.

[6]  K. Izuhara,et al.  Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. , 1996, Blood.

[7]  A. Marshak‐Rothstein,et al.  IL-4 induces Fas resistance in B cells. , 1996, Journal of immunology.

[8]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB , 1996, Nature.

[9]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[10]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[11]  R. Meadows,et al.  Structural basis for IL-4 receptor phosphopeptide recognition by thelRS-1 PTB domain , 1996, Nature Structural Biology.

[12]  P. Majerus,et al.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Paul,et al.  IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. , 1996, Immunity.

[14]  W. Paul,et al.  Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. , 1996, Immunity.

[15]  A. DeFranco,et al.  Activation-induced Association of a 145-kDa Tyrosine-phosphorylated Protein with Shc and Syk in B Lymphocytes and Macrophages (*) , 1996, The Journal of Biological Chemistry.

[16]  P. Musiani,et al.  Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. , 1995, Blood.

[17]  M. White,et al.  PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) , 1995, The Journal of Biological Chemistry.

[18]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[19]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[20]  J. Johnston,et al.  Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Paul,et al.  Interleukin 4 signals through two related pathways. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Paul,et al.  Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis , 1995, Molecular and cellular biology.

[23]  K. Siminovitch,et al.  Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. , 1995, Science.

[24]  T. Blankenstein,et al.  The rat interleukin 4 receptor: coevolution of ligand and receptor. , 1995, Cytokine.

[25]  S. McKnight,et al.  An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.

[26]  J. Bluestone,et al.  IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. , 1994, Journal of immunology.

[27]  G. Klaus,et al.  Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. , 1994, Journal of immunology.

[28]  W. Paul,et al.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth , 1994, Cell.

[29]  M. Nussenzweig,et al.  A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling , 1994, Nature.

[30]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[31]  R. Ashman,et al.  Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. , 1993, Journal of immunology.

[32]  K. Izuhara,et al.  Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of phosphatidylinositol 3-kinase to the IL-4 receptor in a mouse T cell line, HT2. , 1993, The Journal of biological chemistry.

[33]  R. Puri,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. , 1993, Science.

[34]  J. Gutkind,et al.  IL‐4 activates a distinct signal transduction cascade from IL‐3 in factor‐dependent myeloid cells. , 1992, The EMBO journal.

[35]  G. Delespesse,et al.  Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression , 1992, The Journal of experimental medicine.

[36]  W. Paul,et al.  Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .

[37]  J. Banchereau,et al.  Molecular cloning of a cDNA encoding the human interleukin 4 receptor. , 1990, International immunology.

[38]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[39]  A. Miyajima,et al.  Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Alan I. Alpert,et al.  The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.

[41]  W. Paul,et al.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Coligan,et al.  High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. , 1987, Journal of immunology.

[43]  W. Paul,et al.  Regulation of B‐Lymphocyte Activation, Proliferation, and Differentiation , 1987, Annals of the New York Academy of Sciences.

[44]  R. Coffman,et al.  B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. , 1986, Journal of immunology.

[45]  W. Paul,et al.  Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 , 1985, The Journal of experimental medicine.

[46]  W. Paul,et al.  B-cell stimulatory factor 1 activates resting B cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Uhr,et al.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Uhr,et al.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.